Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Treilleux

Showing results (91-100 of 186) with videos related to

Pageof 19
Sort By:
Cancer Research|June 1, 2013
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatmentIsabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, et al.
Cancers|September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistoryMehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
The Journal of Pathology|November 27, 2012
High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glandsChristelle Seigne, Magdalena Auret, Isabelle Treilleux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trialJudith Hugh, John Hanson, Maggie Chon U Cheang, et al.
Breast Cancer Research and Treatment|October 25, 2006
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and reviewValérie Bonadona, Sophie Dussart-Moser, Nicolas Voirin, et al.
Cancer Research|May 18, 2012
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasionJulie A Vendrell, Aurélie Thollet, Nhan T Nguyen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitisVirginie Desestret, Aude Chefdeville, Aurélien Viaccoz, et al.
Cells|April 16, 2020
Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1Elise Berthel, Anne Vincent, Lauriane Eberst, et al.
Aging Cell|June 2, 2022
NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cellsClotilde Raynard, Xingjie Ma, Anda Huna, et al.
The American Journal of Pathology|February 26, 2004
CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytesBruno Salaun, Blandine de Saint-Vis, Nathalie Pacheco, et al.
Pageof 19

Showing results (91-100 of 186) with videos related to

Sort By:
Pageof 19
Cancer Research|June 1, 2013
Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatmentIsabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, et al.
Cancers|September 16, 2020
Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistoryMehdi Brahmi, Tatiana Franceschi, Isabelle Treilleux, et al.
The Journal of Pathology|November 27, 2012
High incidence of mammary intraepithelial neoplasia development in Men1-disrupted murine mammary glandsChristelle Seigne, Magdalena Auret, Isabelle Treilleux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trialJudith Hugh, John Hanson, Maggie Chon U Cheang, et al.
Breast Cancer Research and Treatment|October 25, 2006
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and reviewValérie Bonadona, Sophie Dussart-Moser, Nicolas Voirin, et al.
Cancer Research|May 18, 2012
ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasionJulie A Vendrell, Aurélie Thollet, Nhan T Nguyen, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2015
CSF IgA NMDAR antibodies are potential biomarkers for teratomas in anti-NMDAR encephalitisVirginie Desestret, Aude Chefdeville, Aurélien Viaccoz, et al.
Cells|April 16, 2020
Uncovering the Translational Regulatory Activity of the Tumor Suppressor BRCA1Elise Berthel, Anne Vincent, Lauriane Eberst, et al.
Aging Cell|June 2, 2022
NF-κB-dependent secretome of senescent cells can trigger neuroendocrine transdifferentiation of breast cancer cellsClotilde Raynard, Xingjie Ma, Anda Huna, et al.
The American Journal of Pathology|February 26, 2004
CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytesBruno Salaun, Blandine de Saint-Vis, Nathalie Pacheco, et al.
Pageof 19